Tumores Urológicos

Recomendações de diretriz baseada em evidência para o uso da ressonância magnética no diagnóstico de câncer de próstata clinicamente significante.

1 Abr, 2022 | 12:48h

Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline – Canadian Urological Association Journal

---

Diretriz clínica SEOM-SOGUG | Câncer de bexiga avançado, localizado e de invasão muscular.

1 Abr, 2022 | 11:57h

SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021) – Clinical and Translational Oncology

---

Diretrizes EAU para carcinoma de célula renal.

31 Mar, 2022 | 13:21h

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update – European Urology

---

Diretrizes alemãs para diagnóstico e avaliação prognóstica em tumores de células renais.

25 Mar, 2022 | 15:19h

Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations – World Journal of Urology

---

Guia baseado em evidências para prática clínica | Tratamento atual do carcinoma do úraco.

23 Mar, 2022 | 11:31h

Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice – European Urology Open Science

---

Estudo randomizado | Modalidade de exames de imagem (TC vs. RM) e frequência (7 exames em 60 meses vs. 3 exames em 36 meses) na vigilância do seminoma testicular maligno estágio I.

22 Mar, 2022 | 11:38h

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST) – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

---

Resumo | Diretrizes alemãs baseadas em evidências sobre terapias focais no câncer de próstata localizado.

17 Mar, 2022 | 13:01h

German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy – Urologia Internationalis

---

Estudo de coorte | Radioterapia adjuvante vs. de salvamento precoce após prostatectomia para câncer de próstata pN1.

17 Mar, 2022 | 12:41h

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death – Journal of Clinical Oncology

Comentário: Adjuvant compared to early salvage therapy post prostatectomy in men with PN1 prostate cancer and decreased risk of mortality – Brigham and Women’s Hospital

---

Estudo randomizado | Observação vs. rastreamento com ressonância magnética espinal e tratamento preemptivo da compressão de medula espinal em pacientes com câncer de próstata resistente à castração e metástases espinais.

16 Mar, 2022 | 17:15h

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial – The Lancet Oncology

 

Comentário no Twitter

In @LancetOncology : Brilliant question answered by this RCT👉Any role of screening for malignant spinal cord compression & pre-emptive Rx in asymptomatic mCRPC #prostatecancer ? Answer is "NO". Congrats to @DearnaleyProf & team Free access: https://t.co/8r4yJOYCLA @OncoAlert pic.twitter.com/8oLIwKKOx1

— Neeraj Agarwal (@neerajaiims) March 12, 2022

 

---

M-A | Reavaliação da eficácia da carboplatina para carcinoma urotelial metastático na era da imunoterapia.

15 Mar, 2022 | 12:47h

Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis – European Urology Focus

---